OFI Invest Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.8M Sell
83,920
-968
-1% -$465K 0.37% 58
2026
Q1
$36.3M Sell
84,888
-12,361
-13% -$6.71M 0.48% 50
2025
Q4
$48M Sell
97,249
-10,792
-10% -$6.1M 0.69% 31
2025
Q3
$44.6M Sell
108,041
-336
-0.3% -$156K 0.94% 30
2025
Q2
$37.4M Buy
108,377
+39,752
+58% +$16.6M 0.93% 32
2025
Q1
$31.6M Buy
68,625
+107
+0.2% +$58K 0.83% 41
2024
Q4
$34.4M Buy
+68,518
New +$37.7M 0.81% 36
2024
Q2
$34.4M Buy
66,686
+109
+0.2% +$62.4K 0.91% 29
2024
Q1
$35.8M Buy
66,577
+1,640
+3% +$920K 0.97% 33
2023
Q4
$31.2M Sell
64,937
-898
-1% -$435K 1.05% 34
2023
Q3
$31.5M Sell
65,835
-854
-1% -$455K 1.13% 30
2023
Q2
$34.8M Sell
66,689
-40,318,404
-100% -$21.8B 1.38% 28
2023
Q1
$70.1M Buy
+40,385,093
New +$22.8B 0.36% 59

Other funds holding TMO

OFI Invest Asset Management's TMO Position: Q2 2026 in Review

OFI Invest Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 1.1% in Q2 2026, selling an estimated $465K and leaving 83,920 shares worth $36.8M. The position accounts for 0.37% of the portfolio, ranked #58.

OFI Invest Asset Management first reported a position in TMO in Q1 2023 and has held it in 13 quarters since. The position peaked at $70.1M in Q1 2023. 1,662 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • OFI Invest Asset Management held 83,920 shares of Thermo Fisher Scientific worth $36.8M as of Q2 2026.
  • OFI Invest Asset Management sold 968 Thermo Fisher Scientific shares in Q2 2026, an estimated $465K.
  • Thermo Fisher Scientific made up 0.37% of OFI Invest Asset Management's portfolio in Q2 2026, its #58 holding.
  • OFI Invest Asset Management first reported a position in Thermo Fisher Scientific in Q1 2023 and has held it in 13 quarters since.
  • OFI Invest Asset Management's Thermo Fisher Scientific position peaked at $70.1M in Q1 2023.
  • 1,662 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on OFI Invest Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.